Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Intestinal research

Showing results (91-100 of 832) with videos related to

Pageof 84
Sort By:
Intestinal Research|May 11, 2018
Author's ReplySakiko Hiraoka, Jun Kato, Hiroyuki Okada
Intestinal Research|May 11, 2018
A huge mass causing colonic obstruction at the hepatic flexureChang Hwi Yoon, Byoung Wook Bang, Kye Sook Kwon, et al.
Intestinal Research|July 4, 2017
Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel DiseaseShu-Chen Wei, Ting-An Chang, Te-Hsin Chao, et al.
Intestinal Research|July 4, 2017
<i>NUDT15</i>, <i>FTO</i>, and <i>RUNX1</i> genetic variants and thiopurine intolerance among Japanese patients with inflammatory bowel diseasesToshiyuki Sato, Tetsuya Takagawa, Yoichi Kakuta, et al.
Intestinal Research|July 4, 2017
Impact of inflammatory bowel disease on daily life: an online survey by the Korean Association for the Study of Intestinal DiseasesYoung Sun Kim, Sung-Ae Jung, Kang-Moon Lee, et al.
Intestinal Research|July 4, 2017
Changes in serum levels of lipopolysaccharides and CD26 in patients with Crohn's diseaseDaniéla Oliveira Magro, Paulo Gustavo Kotze, Carlos Augusto Real Martinez, et al.
Intestinal Research|July 4, 2017
Comparison of efficacies of once-daily dose multimatrix mesalazine and multiple-dose mesalazine for the maintenance of remission in ulcerative colitis: a randomized, double-blind studyHaruhiko Ogata, Akihiro Ohori, Haruo Nishino, et al.
Intestinal Research|July 4, 2017
Comparison of efficacy of multimatrix mesalazine 4.8 g/day once-daily with other high-dose mesalazine in active ulcerative colitis: a randomized, double-blind studyHaruhiko Ogata, Nobuo Aoyama, Seiichi Mizushima, et al.
Intestinal Research|July 4, 2017
Familial aggregation of inflammatory bowel disease in patients with ulcerative colitisAkshita Gupta, Sawan Bopanna, Saurabh Kedia, et al.
Intestinal Research|July 4, 2017
Telmisartan-induced sprue-like enteropathy: a case report and a review of patients using non-olmesartan angiotensin receptor blockersHarshal Surendra Mandavdhare, Vishal Sharma, Kaushal K Prasad, et al.
Pageof 84

Showing results (91-100 of 832) with videos related to

Sort By:
Pageof 84
Intestinal Research|May 11, 2018
Author's ReplySakiko Hiraoka, Jun Kato, Hiroyuki Okada
Intestinal Research|May 11, 2018
A huge mass causing colonic obstruction at the hepatic flexureChang Hwi Yoon, Byoung Wook Bang, Kye Sook Kwon, et al.
Intestinal Research|July 4, 2017
Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel DiseaseShu-Chen Wei, Ting-An Chang, Te-Hsin Chao, et al.
Intestinal Research|July 4, 2017
<i>NUDT15</i>, <i>FTO</i>, and <i>RUNX1</i> genetic variants and thiopurine intolerance among Japanese patients with inflammatory bowel diseasesToshiyuki Sato, Tetsuya Takagawa, Yoichi Kakuta, et al.
Intestinal Research|July 4, 2017
Impact of inflammatory bowel disease on daily life: an online survey by the Korean Association for the Study of Intestinal DiseasesYoung Sun Kim, Sung-Ae Jung, Kang-Moon Lee, et al.
Intestinal Research|July 4, 2017
Changes in serum levels of lipopolysaccharides and CD26 in patients with Crohn's diseaseDaniéla Oliveira Magro, Paulo Gustavo Kotze, Carlos Augusto Real Martinez, et al.
Intestinal Research|July 4, 2017
Comparison of efficacies of once-daily dose multimatrix mesalazine and multiple-dose mesalazine for the maintenance of remission in ulcerative colitis: a randomized, double-blind studyHaruhiko Ogata, Akihiro Ohori, Haruo Nishino, et al.
Intestinal Research|July 4, 2017
Comparison of efficacy of multimatrix mesalazine 4.8 g/day once-daily with other high-dose mesalazine in active ulcerative colitis: a randomized, double-blind studyHaruhiko Ogata, Nobuo Aoyama, Seiichi Mizushima, et al.
Intestinal Research|July 4, 2017
Familial aggregation of inflammatory bowel disease in patients with ulcerative colitisAkshita Gupta, Sawan Bopanna, Saurabh Kedia, et al.
Intestinal Research|July 4, 2017
Telmisartan-induced sprue-like enteropathy: a case report and a review of patients using non-olmesartan angiotensin receptor blockersHarshal Surendra Mandavdhare, Vishal Sharma, Kaushal K Prasad, et al.
Pageof 84